Ocular infection secondary to gemella.
OBJECTIVE
To report four cases of ocular infection caused by Gemella species.


METHODS
Microbial identification was carried out using the MicroScan Walkaway system (Dade Behring) and/or Vitek-2 (bioMérieux) and susceptibility testing with either Kirby-Bauer disc diffusion and/or Vitek-2. The paper is presented as an interventional case report.


RESULTS
Four patients developed infection due to Gemella species. All responded to vancomycin or fortified aminoglycosides and broad-spectrum antibiotics.


CONCLUSIONS
Gemella spp. can cause opportunistic infections in the eye.
Hamrah
Pedram
P
Department of Ophthalmology & Visual Sciences, University of Louisville, 301 E. Muhammad Ali Boulevard, Louisville, Kentucky, KY 40202, USA. Pedram.hamrah@louisville.edu
Ritterband
David
D
Seedor
John
J
Eiferman
Richard A
RA
D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D040141:Staphylococcaceae / Q000302:isolation & purification*; D014031:Tobramycin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D014031:Tobramycin